Editor’s Note: Find the latest news and about COVID-19 in the Medscape Coronavirus Resource Center.
Here are the coronavirus stories that Medscape editors around the world think you want to know today:
According to a new study, people with a large amount of viral COVID-19 are less likely to require hospitalization. Researchers studied 205 adults with COVID-19 who were shown at the Langone Medical Center emergency branch of New York University, took nasopharyngeal swabs, and measured the viral load of SARS-CoV-2 RT-PCR tests.
“Patients with severe symptoms and hospitalization had a decrease in diagnostic viral load, but their samples were taken at a later date in the course of the disease,” said researcher Colead Paolo Cotzia, MD. We believe that viral load reflects the time elapsed since the infection began. “
A randomized controlled trial of hydroxychloroquine, an antimalarial drug, in non-hospitalized patients with mild symptoms of COVID-19 did not show that the drug had an advantage, Reuters reported. About 24% of patients who gained hydroxychloroquine on the test had persistent symptoms for 14 days compared to 30% of the placebo group, although this difference is not statistically significant.
The “provides strong evidence that hydroxychloroquine offers no advantages in patients with mild illness,” Neil Schluger, MD, of New York Medical College said at an editorial on theArray
In addition, knowledge of a randomized controlled trial in Spain involving approximately 300 non-hospitalized patients with less than five days of symptoms also did not show advantages for hydroxychloroquine. The results of the HYDR Oxychloroquine control from the UK RECOVERY trial for more than 4,500 hospitalized patients, published on a prepress server on Wednesday, revealed that the drug did not decrease mortality, but was associated with longer hospital remains and a greater threat of death or needing mechanical ventilation.
The Centers for Disease Control and Prevention is preparing rules that will advocate against repeated diagnostic testing for SARS-CoV-2 in others who have become inflamed and have had a symptom solution, Admiral Brett P. Giroir, MD, assistant secretary of physical fitness at the U.S. Department of Health and Human Services. He said on a call with reporters.
“We know that if it has been 10 days since the onset of your symptoms and at least 3 [asymptomatic] days, and that it would possibly happen in the future, even 3 asymptomatic days, are no longer contagious,” Giroir said.
Some other people are evaluated 3 or 6 times, which, according to Giroir, “is not necessary,” at least for the average individual who has moved away from home. Repeated tests will be recommended for other seriously ill people and others with immunosuppression or immune deficiencies, Giroir said. People who fall into a gray domain deserve to consult their doctors, he said.
Members of the U.S. House of Representatives presented a law on Thursday that would make permanent some of the transient adjustments that the Centers for Medicare and Medicaid Services initiated in their telehealth policy, the COVID-19 pandemic.
Bipartisan law would eliminate the maximum of geographic and original restrictions on the use of Medicare telephony, allow phone visits to a patient’s home, and allow rural fitness clinics and federal fitness clinics to provide telephone services.
This week, in the COVID-19 news, a new review said that silent transmission may be fatal to part of the cases, the report advised that other people who practice social estrangement could be smarter and that a squirrel tested positive for bubonic plague. But you haven’t noticed those headlines in Medscape Medical News. This is why.
While front-line fitness staff treat patients with COVID-19, they interact in difficult and exhausting pictures and are also at risk of infection. More than 1,700 people in the world have died.
Medscape has published a commemorative list to commemorate them. We will continue to update this list if unfortunately necessary. Help us make sure this list is complete by submitting names with an age, profession, or specialty and location on this form.
If you want to assign a percentage of other pandemic-like experiences, stories, or considerations, sign up for verbal exchange here.
Victoria Giardina is Medscape’s editorial intern. In the past she has written for The Dr. Oz Show and lately has been a national lifestyle editor for her campus. You can reach her on [email protected] or on Twitter @VickyRGiardina.
Follow Medscape on Facebook, Twitter, Instagram and YouTube and Ellie Kincaid on Twitter. Here’s how to send Medscape a tip.
Medscape Medical News © 2020
You’ve already decided on My Alerts
Click the topic below to get emails when new items become available.